Ophthotech Signs Marketing Deal For Eye Drug With Novartis; Shares Surge – RTT News

Ophthotech Signs Marketing Deal For Eye Drug With Novartis; Shares Surge
RTT News
Fovista, a developmental stage drug, is being developed for the treatment of wet age-related macular degeneration. If approved, Fovista is expected to be first to market in this class of therapies for wet AMD. Age-related macular degeneration is a

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment